Is Humacyte, Inc. (HUMA) a Buy, Sell, or Hold?
Humacyte, Inc.
NASDAQ:HUMA
$0.6933 USD
-$0.01 (-1.97%)
- Volume
- 2.16M
- Average Volume
- 10.52M
- Market Capitalization
- $116.47M
- P/E Ratio
- -1.18
- Dividend Yield
- 0.00%
- Price Target
- $5.50
- Year High
- $2.84
- Year Low
- $0.55
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $3.93
Analyst Rating
Strong Sell
1 Rating Score
UPSIDE/DOWNSIDE
-87.4% DOWNSIDE
$5.50 Price Target
UPSIDE/DOWNSIDE HIGH
-93.1% DOWNSIDE
$10.00 Price Target High
UPSIDE/DOWNSIDE LOW
-76.9% DOWNSIDE
$3.00 Price Target Low
INSIDER TRADING
Shares
$- Last Quarter
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| H.C. Wainwright | Swayampakula Ramakanth | $3 | $1.35 | 2025-12-01 06:35 AM | 122.2% |
| Barclays | Matt Miksic | $3.5 | $1.47 | 2025-08-27 04:37 AM | 138.1% |
| Piper Sandler | Matt O'Brien | $6 | $4.86 | 2024-10-18 03:51 AM | 23.5% |
| BTIG | Ryan Zimmerman | $10 | $4.86 | 2024-10-18 01:41 AM | 105.8% |
| Cowen & Co. | Cowen Cowen | $5 | $2.2075 | 2022-12-20 05:49 AM | 126.5% |
| Piper Sandler | Matt O'Brien | $4 | $5.37 | 2022-05-15 05:11 PM | -25.5% |